134 related articles for article (PubMed ID: 21274828)
1. Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries.
Freyhardt P; Zeller T; Kröncke TJ; Schwarzwaelder U; Schreiter NF; Stiepani H; Sixt S; Rastan A; Werk M
Rofo; 2011 May; 183(5):448-55. PubMed ID: 21274828
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial.
Werk M; Langner S; Reinkensmeier B; Boettcher HF; Tepe G; Dietz U; Hosten N; Hamm B; Speck U; Ricke J
Circulation; 2008 Sep; 118(13):1358-65. PubMed ID: 18779447
[TBL] [Abstract][Full Text] [Related]
3. [Remote results of angioplasty using drug-coated balloons in lesions of the femoropopliteal segment].
Zatevakhin II; Shipovskiĭ VN; Tursunov SB; Bagdat'ev VE; Dzhurakulov ShR
Angiol Sosud Khir; 2014; 20(4):64-8. PubMed ID: 25490359
[TBL] [Abstract][Full Text] [Related]
4. Review of clinical data with Paccocath- coated balloon catheters.
Schnorr B; Speck U; Scheller B
Minerva Cardioangiol; 2011 Oct; 59(5):431-45. PubMed ID: 21983304
[TBL] [Abstract][Full Text] [Related]
5. What are the potential limitations of drug coated balloons and possible ways to overcome.
Werk M
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):23-8. PubMed ID: 26771723
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
Tepe G; Zeller T; Albrecht T; Heller S; Schwarzwälder U; Beregi JP; Claussen CD; Oldenburg A; Scheller B; Speck U
N Engl J Med; 2008 Feb; 358(7):689-99. PubMed ID: 18272892
[TBL] [Abstract][Full Text] [Related]
7. Drug coated balloons below-the-knee: just too early?
Fanelli F; Cannavale A
J Cardiovasc Surg (Torino); 2016 Feb; 57(1):18-22. PubMed ID: 26771722
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine and restenosis after femoropopliteal angioplasty.
Kovacevic T; Van Der Loo B; Amann-Vesti BR; Rousson V; Koppensteiner R
J Endovasc Ther; 2004 Jun; 11(3):302-9. PubMed ID: 15174910
[TBL] [Abstract][Full Text] [Related]
9. Two-Year Mortality After Angioplasty of the Femoro-Popliteal Artery with Uncoated Balloons and Paclitaxel-Coated Balloons-A Pooled Analysis of Four Randomized Controlled Multicenter Trials.
Albrecht T; Schnorr B; Kutschera M; Waliszewski MW
Cardiovasc Intervent Radiol; 2019 Jul; 42(7):949-955. PubMed ID: 30843092
[TBL] [Abstract][Full Text] [Related]
10. Treatment paradigms for the superficial femoral artery: are they a-changin?
Scheinert D
JACC Cardiovasc Interv; 2012 Mar; 5(3):339-40. PubMed ID: 22440501
[No Abstract] [Full Text] [Related]
11. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
[TBL] [Abstract][Full Text] [Related]
12. Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug-coated balloon in a swine femoral artery model.
Yazdani SK; Pacheco E; Nakano M; Otsuka F; Naisbitt S; Kolodgie FD; Ladich E; Rousselle S; Virmani R
Catheter Cardiovasc Interv; 2014 Jan; 83(1):132-40. PubMed ID: 23703778
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763.
Miller AA; Rosner GL; Egorin MJ; Hollis D; Lichtman SM; Ratain MJ
Clin Cancer Res; 2004 Dec; 10(24):8325-31. PubMed ID: 15623609
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-coated balloons - Survey of preclinical data.
Schnorr B; Kelsch B; Cremers B; Clever YP; Speck U; Scheller B
Minerva Cardioangiol; 2010 Oct; 58(5):567-82. PubMed ID: 20948503
[TBL] [Abstract][Full Text] [Related]
15. Comparative angioscopic evaluation of neointimal coverage and thrombus between TAXUS-Express and TAXUS-Liberté stents: is the stent platform type associated with the vascular response?
Yamamoto M; Takano M; Murakami D; Okamatsu K; Seino Y; Mizuno K
Int J Cardiol; 2010 Dec; 145(3):587-9. PubMed ID: 20580101
[No Abstract] [Full Text] [Related]
16. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
[TBL] [Abstract][Full Text] [Related]
17. Two-year Review on Mortality and Morbidity after Femoropopliteal Drug-coated Balloon Angioplasty in the Randomized EffPac Trial.
Teichgräber U; Lehmann T; Aschenbach R; Thieme M; Zeller T; Beschorner U; Scheinert D
Radiology; 2020 Sep; 296(3):638-640. PubMed ID: 32692299
[No Abstract] [Full Text] [Related]
18. [Balloon dilation alone in treatment of arteriosclerotic stenosis or occlusions of femoropopliteal arteries].
Li W; Zhang XM; Zhang XM; Shen CY; Li QL; Jiang JJ; Jiao Y
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1188-91. PubMed ID: 18067714
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
Bulitta JB; Zhao P; Arnold RD; Kessler DR; Daifuku R; Pratt J; Luciano G; Hanauske AR; Gelderblom H; Awada A; Jusko WJ
Cancer Chemother Pharmacol; 2009 May; 63(6):1049-63. PubMed ID: 18791718
[TBL] [Abstract][Full Text] [Related]
20. Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.
Silber S; Hamburger J; Grube E; Pfisterer M; Belardi J; Webb J; Zmudka K; Nienaber C; Hauptman K; Rutsch W; Dawkins K; Drzewiecki J; Koglin J; Colombo A
Herz; 2004 Mar; 29(2):171-80. PubMed ID: 15057438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
